As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: April 6, 2012
by University of California
Researchers at the University of California, San Diego, and Veterans Affairs San Diego Healthcare System have shown that elevated pulse pressure may increase the risk of cerebrovascular disease in older adults with Alzheimer’s disease. Their study has been published in the early online edition of Journal of Alzheimer’s Disease in advance of the June 5 print publication.
The findings may have treatment implications, since some antihypertensive medications specifically address the pulsatile component of blood pressure. Pulse pressure — the difference between systolic and diastolic pressure — is one measure of the pulsatile component of blood pressure. Pulse pressure increases substantially with age, partially due to hardening of the arteries.
Hypertension is a common risk factor for Alzheimer’s, but the use of antihypertensive medications to prevent dementia has had mixed results. Most studies examining the effects of blood pressure on the risk of Alzheimer’s have focused on standard measures of blood pressure, the systole and diastole readings. However, scientists theorized that pulse pressure elevation may impair the clearance of beta amyloid — a hallmark of Alzheimer’s — from the brain. Other studies have suggested that pulse pressure elevation may contribute to Alzheimer’s risk indirectly by increasing the risk of cerebrovascular disease.
The researchers, led by Mark W. Bondi, Ph.D., of VA San Diego Healthcare System and UC San Diego Department of Psychiatry, looked at 65 patients who later met the criteria for AD at autopsy. These patients were examined before death for relationships among blood pressure and neuropathologic markers. More than half of them were found, at autopsy, to have cerebrovascular disease.
“The association between PP and CVD was independent of dementia severity and the presence of other vascular risk factors,” said Bondi. “Interestingly, standard measures of blood pressure were not significantly associated with the presence of CVD.”
The study suggests several conclusions: that elevated blood pressure in older adults with Alzheimer’s is related to cerebrovascular disease but not Alzheimer’s pathology; that cerebrovascular disease may be more closely associated with pulse pressure than systolic or diastolic pressure; and that, in Alzheimer’s patients, pulse pressure elevation may be influencing cognition through effects on cerebrovascular disease.
The study’s first author, Daniel A. Nation, Ph.D., of the VA San Diego Healthcare System, concluded the findings offer possible treatment implications. “Antihypertensive treatments targeting the pulsatile component of blood pressure may reduce the vascular contribution to cognitive impairment in AD patients or in individuals at risk of AD.”
Additional contributors include Lisa Delano-Wood, Ph.D., Christina E. Wierenga, Ph.D., and Amy J. Jak, Ph.D., VA San Diego and UC San Diego Department of Psychiatry; Katherine J. Bangen, Ph.D., UC San Diego Department of Psychiatry; Lawrence A. Hansen, M.D., UC San Diego Departments of Neurosciences and Pathology; Douglas R. Galasko, M.D., VA San Diego and UC San Diego Department of Neurosciences; and David P. Salmon, Ph.D., UC San Diego Department of Neurosciences.
The study was supported by the Alzheimer’s Association and the National Institute of Health.
A new comprehensive study from Florida State University (FSU) finds no evidence to support the idea that personality changes begin before the clinical onset of mild cognitive impairment (MCI) or dementia. MCI is an intermediate...
On the evening of Monday November 27th, join us for conversation and cocktails with award-winning journalist, editor and author Tina Brown, and Indigo’s CEO Heather Reisman. Hear from Tina Brown about her eight-year tenure at Vanity...
The presence of TAR DNA-binding protein 43 (TDP-43) in the hippocampus on postmortem examination is associated with increased rates of hippocampal atrophy in patients with Alzheimer’s disease (AD), new research suggests. This association was greatest...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.